SNY Stock Price, Chart, Stats & News

Sanofi
Save
SNY chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 72.34% |
Operating margin | 13.58% |
Pretax margin | 12.89% |
Net margin | 16.72% |
Effective tax rate | 17.33% |
ROA | 6.16% |
ROE | 10.82% |
D/E | 0.28x |
Interest coverage ratio | 11.73x |
SNY valuation
P/E | 18.34x |
P/S | 2.11x |
P/B | 1.39x |
P/CF | 10.65x |
P/FCF | 11.93x |
P/OCF | 10.65x |
PEG | -0.31x |
EV multiple | 6.79x |
About
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products.
Similar securities
Based on sector and market capitalization
Report issue











